Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Literature DB >> 15126610

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Petra van der Groep, Alwin Bouter, Richard van der Zanden, Fred H Menko, Horst Buerger, Rene H M Verheijen, Elsken van der Wall, Paul J van Diest.

Abstract

Entities: Disease Gene

Mesh：

Substances：
ErbB Receptors

Year: 2004 PMID： 15126610 DOI： 10.1093/jnci/djh114

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. The pathology of hereditary breast cancer.

Authors: Emiliano Honrado; Javier Benítez; José Palacios
Journal: Hered Cancer Clin Pract Date: 2004-07-15 Impact factor: 2.857

2. Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data.

Authors: P van der Groep; A Bouter; R van der Zanden; I Siccama; F H Menko; J J P Gille; C van Kalken; E van der Wall; R H M Verheijen; P J van Diest
Journal: J Clin Pathol Date: 2006-04-07 Impact factor: 3.411

3. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

Authors: Socorro María Rodríguez-Pinilla; David Sarrió; Emiliano Honrado; Gema Moreno-Bueno; David Hardisson; Francisco Calero; Javier Benítez; José Palacios
Journal: J Clin Pathol Date: 2006-11-14 Impact factor: 3.411

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

1. The pathology of hereditary breast cancer.

2. Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data.

3. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

4. Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.

Review 5. Advances in breast cancer: pathways to personalized medicine.

6. Immunophenotyping invasive breast cancer: paving the road for molecular imaging.

Review 7. Pathology of hereditary breast cancer.

8. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.

9. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer.

10. HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.